Key Takeaway: Vivani Medical has released a business update alongside its financial results for the fourth quarter and full year of 2024. The report includes key financial metrics and insights into the company's performance. Further details on specific achievements or challenges faced during the year were not provided in the article.
Price reaction · baseline $1.11 (2025-03-28 close) · hit pre-market · clean, no other VANI news in the window
day 0 close
-5.4%
day 1
-8.1%
day 3 · peak
-10.8%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight
Full Press Release Details
Blog Post
vivani | March 31, 2025
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results